{
"NDC": {
"NDCCode": "67877-882-71",
"PackageDescription": "1 BOTTLE in 1 CARTON (67877-882-71) / 1 GRANULE, FOR SUSPENSION in 1 BOTTLE",
"NDC11Code": "67877-0882-71",
"ProductNDC": "67877-882",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Rivaroxaban",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Rivaroxaban",
"DosageFormName": "GRANULE, FOR SUSPENSION",
"RouteName": "ORAL",
"StartMarketingDate": "20250707",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA218502",
"LabelerName": "Ascend Laboratories, LLC",
"SubstanceName": "RIVAROXABAN",
"StrengthNumber": "155",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2025-07-07",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20250707",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}